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ARTICLE OPEN
Pioneering function of Isl1 in the epigenetic control
of cardiomyocyte cell fate
Rui Gao1,2,3, Xingqun Liang4, Sirisha Cheedipudi1, Julio Cordero1,2,3, Xue Jiang4, Qingquan Zhang 4, Luca Caputo 1, Stefan Günther1,
Carsten Kuenne1, Yonggang Ren1,2,3, Shoumo Bhattacharya5, Xuejun Yuan1, Guillermo Barreto 1, Yihan Chen4, Thomas Braun1,
Sylvia M. Evans6, Yunfu Sun4 and Gergana Dobreva 1,2,3,7
Generation of widely differing and specialized cell types from a single totipotent zygote involves large-scale transcriptional changes
and chromatin reorganization. Pioneer transcription factors play key roles in programming the epigenome and facilitating
recruitment of additional regulatory factors during successive cell lineage specification and differentiation steps. Here we show that
Isl1 acts as a pioneer factor driving cardiomyocyte lineage commitment by shaping the chromatin landscape of cardiac progenitor
cells. Using an Isl1 hypomorphic mouse line which shows congenital heart defects, genome-wide profiling of Isl1 binding together
with RNA- and ATAC-sequencing of cardiac progenitor cells and their derivatives, we uncover a regulatory network downstream of
Isl1 that orchestrates cardiogenesis. Mechanistically, we show that Isl1 binds to compacted chromatin and works in concert with the
Brg1-Baf60c-based SWI/SNF complex to promote permissive cardiac lineage-specific alterations in the chromatin landscape not
only of genes with critical functions in cardiac progenitor cells, but also of cardiomyocyte structural genes that are highly expressed
when Isl1 itself is no longer present. Thus, the Isl1/Brg1-Baf60c complex plays a crucial role in orchestrating proper cardiogenesis
and in establishing epigenetic memory of cardiomyocyte fate commitment.
Cell Research (2019) 29:486–501; https://doi.org/10.1038/s41422-019-0168-1
INTRODUCTION
The differentiation of stem/progenitor cells into distinct lineages
involves a coordinated series of large-scale transcriptional changes
and chromatin reorganization. Tissue specific transcription factors
cooperate with epigenetic modifiers to program the epigenome
and establish cellular identity, which is further maintained by
epigenetic regulatory mechanisms. To initiate cell programming, a
special type of transcription factors, named pioneer transcription
factors, engage developmentally silenced genes embedded in
“closed” chromatin covered by nucleosomes.1–4 Pioneer factor
binding on its own is not sufficient for gene activation, but it
imparts competence for transcription by chromatin opening.
Chromatin opening facilitates subsequent recruitment of addi-
tional transcription factors and other regulatory proteins, which
work in concert to induce a cell-type-specific gene expression
program during the successive steps involved in lineage
specification and differentiation.1–4 During cardiogenesis, multiple
transcription factors cooperate and are integrated in regulatory
networks, which strictly control a transcriptional program that
ensures proper heart development.5–8
Isl1, a LIM-homeodomain transcription factor is transiently
expressed in second heart field (SHF) progenitor cells before their
differentiation and integration into the heart tube.9 These cells are
added to the arterial and venous poles of the heart tube allowing its
continuous growth and complex morphogenetic patterning.8–10
Defects in specification, deployment and differentiation of SHF
cardiac progenitor cells (CPCs) are largely responsible for the high
rate of congenital cardiac abnormalities in humans, underscoring
the importance of a more integrated understanding of the
mechanisms driving SHF-mediated cardiogenesis.11 The key role of
Isl1 in SHF development is evident from genetic studies in mice,
showing that Isl1-deficient mouse embryos lack all structures
derived from the SHF including the right ventricle (RV), the outflow
tract (OFT) and large portions of the atria, since Isl1 is required for
proliferation, survival, migration of SHF CPCs and their differentiation
into the different cardiac lineages.9,12–14 Importantly, recent studies
identified association of ISL1 variants and deletion with congenital
heart disease.15–17 Despite the critical role of Isl1 in cardiac
development and disease, detailed insights into its molecular mode
of action are critically missing.
The Brg1-based SWI/SNF complex acts as a global transcrip-
tional regulator by altering chromatin structure and DNA
accessibility. Brg1, the catalytic component of the complex,
utilizes energy from ATP hydrolysis to disrupt or reposition
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nucleosomes, thereby activating or repressing transcription,
depending on the inclusion or exclusion of specific accessory
factors.18 Mice haploinsufficient for Brg1 exhibit cardiac morpho-
genetic defects, suggesting a key role of Brg1 in heart
development.19 The functional versatility of the Brg1-based SWI/
SNF complex is highly determined by the dynamic assembly of
BAF subunits, some of which show a cell-type-specific expression
pattern. Consistently, depletion of the cardiac-specific subunit of
the Brg1 complex Baf60c leads to severe cardiac abnormalities.20
Moreover, Baf60c mediates the interaction between the core
cardiac transcription factors Tbx5, Nkx2-5, Gata4 and the Brg1
complex, thereby regulating expression of their target genes.20
Importantly, Baf60c was shown to promote cardiomyocyte fate
and differentiation of non-cardiogenic mesoderm in concert with
Gata4 and Tbx5 by facilitating the binding of Gata4 to its cardiac-
specific target genes and inducing hierarchical downstream
regulatory networks.21
Here we show that Isl1 acts as a pioneer factor in cardiomyocyte
fate commitment by shaping the epigenetic landscape of CPCs.
On the one hand, Isl1 binds to and regulates the expression of
transcription factors, epigenetic modifiers and signaling molecules
with critical functions and high expression in CPCs. On the other
hand, in CPCs Isl1 also binds to cardiomyocyte structural genes
and genes involved in cardiomyocyte function, well before these
genes become highly expressed in differentiating cardiomyocytes.
Our data further demonstrate that Isl1 binds to closed chromatin
and works in concert with the Brg1-Baf60c-based SWI/SNF
complex to induce permissive cardiac lineage-specific alterations
in the chromatin landscape of CPCs enabling the subsequent
activation of genes defining cardiomyocyte identity in cardiomyo-
cytes, when Isl1 itself is switched off.
RESULTS
Isl1 hypomorphic embryos show defects in cardiac
morphogenesis, cardiomyocyte differentiation and maturation
To investigate the mechanisms through which Isl1 regulates
cardiogenesis, we utilized an Isl1 knockout mouse line, which
shows early embryonic lethality9,22 and an Isl1 hypomorphic
mouse line (Supplementary information, Fig. S1a–d),23 which
survives until birth, allowing us to analyze the role of Isl1 in SHF
structures that are dependent on Isl1, as well as during later stages
of embryonic heart development. Consistent with human studies
which identified ISL1 variations and deletions contributing to
congenital heart disease,16,17 all Isl1 hypomorphic mice (Isl1-f;neo/
f;neo) died shortly after birth with severe cardiac malformations.
Wholemount and histological analyses of Isl1 hypomorphic
embryos at E12.5 (Fig. 1a, b) and E17.5 (Fig. 1c, d) revealed
various degrees of cardiac outflow tract (OFT) septation abnorm-
alities, including partial OFT septal defects with aortic stenosis and
misalignment (Fig. 1a, middle panel, Fig. 1b) and persistent
truncus arteriosus (PTA) (Fig. 1a, right panel, Fig. 1c, d). Nearly all
Isl1 hypomorphic mice presented ventricular septal defects (VSDs)
and atrial septal defects (ASDs) (Fig. 1d). MRI and 3D reconstruc-
tions confirmed the presence of various cardiac outflow tract
(OFT) abnormalities, VSDs and ASDs (Fig. 1e, f).
Detailed histological analysis revealed that the right ventricular
compact myocardium of Isl1 hypomorphic mice was thinner than
that of control littermates at E12.5 (Fig. 2a, c) and E17.5 (Fig. 2b, c).
In contrast, left ventricular wall thickness in Isl1 hypomorphic mice
was relatively normal in embryos with no significant ventricular
dilation (Fig. 2a–c). Co-immunostaining for alpha-actinin and BrdU
together with staining for MF20 and BrdU at E12.5 and E17.5
revealed significantly decreased cardiomyocyte proliferation in Isl1
hypomorphic hearts and markedly decreased MF20 immunor-
eactivity (Fig. 2d, e; Supplementary information, Fig. S1e, f).
Further, qPCR analysis for Myh6 and Myh7 as well as immunostain-
ing for MF20 on E15.5 cardiomyocytes in culture revealed
decreased expression of cardiac myosins and less prominent
sarcomere structures (Fig. 2f, g), suggesting defects in differentia-
tion of cardiac progenitors and in sarcomeric maturation.
Isl1 orchestrates a complex gene regulatory network driving
cardiogenesis
To gain insight into the molecular mechanisms underlying Isl1
function in cardiogenesis we performed RNA-Seq from dissected
pharyngeal mesoderm and hearts of E8.75 Isl1 knockout embryos
as well as OFT and RV of E10.5 Isl1 hypomorphic embryos,
structures derived from the Isl1+ SHF CPCs (Fig. 3a, b;
Supplementary information, Fig. S1a–d, Tables S1 and S2). We
identified 569 differentially expressed genes in E8.75 Isl1 knockout
embryos and 899 differentially expressed genes in OFT and RV of
E10.5 Isl1 hypomorphic embryos (fold change >1.5; log2 fold
change <−0.58, >0.58; p-value < 0.05, Supplementary information,
Fig. S2a–d). Gene Ontology (GO) analysis revealed over-
representation for GO terms linked to cardiac muscle contraction,
heart development, atrial septum and OFT morphogenesis in
genes downregulated in E8.75 Isl1 knockout embryos, whereas
genes involved in proximal distal pattern formation were over-
represented in upregulated genes (Fig. 3a). At E10.5, in addition to
many transcriptional regulators of cardiac morphogenesis, we
found significant overrepresentation of genes involved in cell
adhesion and differentiation that have been shown to play key
role in cardiac looping morphogenesis, cushion formation, neural
crest addition, ventricular and OFT septation (Fig. 3b). Interest-
ingly, we identified genes involved in erythroid development and
hemogenic lineage specification in genes upregulated upon Isl1
loss (Fig. 3b).
Next, we performed chromatin immunoprecipitation followed
by sequencing (ChIP-Seq) to map the genome-wide binding of Isl1
in dissected cardiogenic regions of E8.25-E9 embryos and in ESC-
derived CPCs to identify Isl1 primary downstream targets
(Supplementary information, Tables S3 and S4). 71% of genes
bound by Isl1 in ESC-derived CPCs were also bound in E8.25-E9
embryos (Fig. 3c). Importantly, 75% of genes deregulated in E8.75
Isl1 knockout embryos were bound by Isl1, whereas 67% of genes
deregulated in OFT and RV of E10.5 Isl1 hypomorphic embryos
were bound by Isl1 (Fig. 3c). Gene network analysis uncovered
distinct groups of Isl1 primary downstream targets (Fig. 3d). These
included: (i) transcription factors and epigenetic modifiers, such as
Myocd,12 Mef2c, Hand2,24 known Isl1 downstream targets, and
other key regulators of cardiac development, such as Gata4/5,
Tbx5/20, Msx2, Hopx, Baf60c (Smarcd3); (ii) signaling molecules,
such as Fgf10,25 and other key components of the Wnt, Bmp,
Notch and Fgf signaling pathways; (iii) cardiomyocyte structural
genes and genes involved in cardiac contraction, such as Ttn, Ryr2,
Mlc1v, Tmod1, Tpm1, Mybpc3. The observation that Isl1 binds to
cardiac structural genes is consistent with the disrupted sarco-
merogenesis in Isl1 hypomorphic embryos but is somewhat
surprising because cardiac structural genes are only highly
expressed when Isl1 transcription is turned off.
GO analysis after intersection of the RNA-Seq data with ChIP-
Seq data revealed overrepresentation of GO terms linked to heart
development, cell adhesion and differentiation, atrial septum and
outflow tract morphogenesis, as well as cardiac muscle fiber
development and cardiac conduction (Fig. 3e–g). This is consistent
with the defects observed in Isl1 hypomorphic embryos.
Importantly, we observed enrichment of GO terms involved in
response to hypoxia in E8.75 embryos (Fig. 3e) consistent with the
critical role of Isl1 in regulating SHF progenitor cell function in
response to spatial differences in oxygenation during cardiogen-
esis.26 Expression analysis confirmed the significant downregula-
tion of selected genes involved in OFT development in dissected
pharyngeal mesoderm and OFT regions of E8.5 embryos and in
dissected OFT and RV of E10.5 Isl1 hypomorphic embryos
(Supplementary information, Fig. S2e, f). Furthermore,
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cardiomyocyte structural and contraction genes were significantly
downregulated in dissected OFT and RV of E10.5 and RV of E13.5
Isl1 hypomorphic embryos (Supplementary information, Fig. S2f,
g). In contrast, no differences were observed in LV of Isl1
hypomorphic embryos (Supplementary information, Fig. S2h).
Isl1 directly bound genes encoding structural and contractile
components of cardiomyocytes. This, together with the down-
regulation of expression of these genes in Isl1 hypomorphs at later
developmental time points when Isl1 is no longer expressed,
support the hypothesis that Isl1 might play a decisive role in
establishing a transcriptional memory of cardiomyocyte lineage
fate commitment during heart development.27,28 To further
confirm the transient requirement of Isl1 in CPCs for expression
of such genes for structural and contractile cardiomyocyte
components, we knocked down Isl1 at distinct stages of directed
cardiac differentiation of mouse embryonic stem cells (mESCs)29
(Fig. 4a; Supplementary information, Fig. S3a, b): at day 4 during
the differentiation of mesodermal precursors into cardiac pro-
genitors; or at day 8, after the appearance of beating cardiomyo-
cytes. Isl1 mRNA levels were high at both stages in control cells
(Supplementary information, Fig. S3c). In all our ESC-based
experiments we used Nkx2-5–GFP mESCs, which allows monitor-
ing of the differentiation efficiency of ESCs (Supplementary
information, Fig. S3d–f). Importantly, cardiomyocyte marker genes
and Isl1 direct targets were significantly downregulated at day 10
of cardiomyocyte differentiation only when Isl1 was down-
regulated at day 4 but not at day 8 (Fig. 4a). Taken together,
these data support the requirement of Isl1 in CPCs in setting up a
transcriptional program to ensure proper cardiomyocyte
differentiation.
Fig. 1 Reduced Isl1 expression leads to defects in cardiac morphogenesis. a, bWholemount and histological analysis of E12.5 hearts of control
and Isl1 hypomorphs littermates showing impaired septation of the aorta (Ao) and pulmonary artery (PA) in Isl1 hypomorphs. Examples of Isl1
hypomorph showing partial septation of the aorta and the pulmonary artery with misaligned and hypoplastic aorta (a, middle panel, and b),
and Isl1 hypomorph showing persistent truncus arteriosus (PTA, arrow). Cushion, c; Aorta, Ao; left ventricle, LV; right ventricle, RV.
c Macroscopic appearance of E17.5 control and Isl1 hypomorphic heart with PTA (arrow). d Histological analysis of Isl1 hypomorphic hearts at
E17.5 showing atrial septal defect (ASD, arrow), ventricular septal defect (VSD, arrow) and PTA compared to control hearts. At E17.5, a
proportion of the mutant hearts are dilated. Atrial septum, AS. e, f MRI and 3D reconstruction of control and Isl1 hypomorphic hearts at
E15.5 showing PTA, VSD and ASD (e) or other complex outflow tract phenotypes (f), e.g. right aortic arch (f, middle panel) and aortic vascular
ring (AVR) (f, right panel). Aorta, Ao; aortic arch, AoA; pulmonary artery, PA; trachea, Tr; left ventricle, LV; right ventricle, RV; as, atrial septum;
atrial septal defect (ASD), ventricular septal defect (VSD)
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Baf60c is a key Isl1 downstream target
Epigenetic mechanisms are central to establishment and main-
tenance of transcriptional memory.28,30–33 To find epigenetic
modifiers employed by Isl1 to establish inheritance of cardiomyo-
cyte lineage identity, and to further identify genes directly
regulated by Isl1 in CPCs, we performed RNA-Seq of sorted
Nkx2-5–GFP+CPCs derived by differentiation of control or Isl1−/−
Nkx2-5–GFP mESCs (Supplementary information, Fig. S4a, b). We
identified 1014 differentially expressed genes (fold change >1.5;
log2 fold change <−0.58, >0.58; p-value < 0.05, Fig. 4b, Supple-
mentary information, Fig. S4c, d, Table S5). Intersection of this
RNA-Seq data to ChIP-Seq data from ESC-derived CPCs revealed
59.5% overlap and identified 603 genes that were bound by Isl1 in
CPCs and were deregulated upon Isl1 loss (Fig. 4c). GO analysis of
genes downregulated in Isl1−/− CPCs that were bound by Isl1
revealed over-representation of GO terms linked to cell adhesion,
positive regulation of transcription and heart development
(Fig. 4e). In contrast, upregulated genes were enriched for genes
involved in hematopoiesis (Supplementary information, Fig. S4e),
consistent with the results from Isl1 loss-of-function embryos.
Given the antagonistic relationship between hemangiogenic and
cardiogenic mesoderm specification,34 this might suggest that Isl1
Fig. 2 Reduced Isl1 expression leads to defects in cardiomyocyte proliferation, differentiation and maturation. a–c Reduced wall thickness of
right ventricle in Isl1 hypomorphic hearts compared to the control littermates at E12.5 (a, c) and E17.5 (b, c). Left ventricle wall thickness in Isl1
hypomorphic hearts is largely comparable to the controls when mutant hearts are not significantly dilated. Data represent mean ± SEM, n= 6.
d Co-immunostaining of control and Isl1 hypomorphic right ventricles with BrdU and α-actinin at E12.5. e Percentage of BrdU-labeled
cardiomyocytes (BrdU+/α-actinin+ cells) in RV free wall at E12.5, showing a marked reduction in the number of proliferating cardiomyocytes in
Isl1 hypomorphs. Data represent mean ± SEM, n= 4. f Markedly reduced MF20 staining and less prominent sarcomere structure in
cardiomyocytes isolated from control and Isl1 hypomorphic E15.5 hearts. g Relative Myh1, Myh6 and Myh7 mRNA expression in isolated Isl1
hypomorphic cardiomyocytes compared to control cardiomyocytes. Statistical significance in this and all other Figs., unless otherwise stated,
was determined by two tailed student t-test *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.005
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is important for establishing cardiac fate and prevents the
acquisition of hemogenic fate. Comparison of Isl1 primary
downstream targets deregulated in E8.75 Isl1 knockout embryos
and Isl1 knockout ESC-derived CPCs identified known Isl1 down-
stream targets, such as Myocd and Mef2c,24 as well as many novel
primary downstream targets with a role in cardiogenesis (Fig. 4d,
Supplementary information, Fig. S4f). One of the targets, Baf60c
(Smarcd3), a cardiac-specific component of the Brg1-based SWI/
SNF chromatin remodeling complex plays a crucial role in heart
development.19,20 Baf60c levels were significantly decreased in Isl1
hypomorphic embryos and Isl1 knockout embryos, confirming
Baf60c as a primary downstream target of Isl1 (Fig. 4f,
Article
490
Cell Research (2019) 29:486 – 501
Supplementary information, Fig. S4f, g). To address whether
Baf60c may play a role in mediating Isl1 function in cardiogenesis
we performed RNA-Seq of sorted Nkx2-5–GFP+CPCs derived by
directed differentiation of control or Baf60c knockdown Nkx2-
5–GFP mESCs.29 The RNA-Seq data identified 1771 differentially
expressed genes following Baf60c depletion (fold change >1.5;
log2 fold change <−0.58, >0.58; p-value < 0.05, Supplementary
information, Fig. S4h, i, Table S6). GO analysis of downregulated
genes upon Baf60c depletion showed that Baf60c activates genes
involved in cardiac muscle contraction, sarcomere organization
and ion transport but represses genes involved in anterior/
posterior pattern specification (Fig. 4g). Intersection of the RNA-
Seq datasets from Isl1 KO and Baf60c knockdown ESC-derived
CPCs showed that 42.6% of the genes deregulated by Isl1 loss-of-
function are also deregulated upon Baf60c knockdown (Fig. 4h)
and revealed that genes activated by both Isl1 and Baf60c are
involved in cardiac muscle contraction and sarcomere organiza-
tion (Fig. 4i). These results indicate that Baf60c may work in an axis
with Isl1 to promote chromatin reorganization at cardiomyocyte
structural and contractile protein encoding genes in CPCs well
before these genes are highly expressed in differentiating
cardiomyocytes.
Isl1 works in concert with the Brg1-based SWI/SNF complex to
regulate its target gene expression
Baf60c is a cardiac-specific subunit of the Brg1-based SWI/SNF
complex, which plays an important role in heart development.19
To analyze whether Isl1 may also work in concert with the Brg1-
Baf60c based SWI/SNF complex we first analyzed whether Isl1
interacts with Brg1 and Baf60c. Co-immunoprecipitation experi-
ments in ESC-derived CPCs revealed that Isl1 binds to both Brg1
and Baf60c (Supplementary information, Fig. S5a). The binding of
Isl1 to Brg1 was further validated in E8.75-E9 embryos (Fig. 5a).
Comparison of ChIP-Seq data for Brg135,36 and Isl1 showed
significant co-occupancy of Brg1 and Isl1 at Isl1 binding sites
(Fig. 5b–d). Furthermore, 59.3% of the genes bound by Isl1 were
bound by Brg1, while 44% of the genes deregulated by Isl1 loss of
function were concomitantly bound by Isl1 and Brg1 (Fig. 5e),
suggesting that Isl1 may work together with the Brg1-Baf60c
complex to regulate nucleosomal structure and expression of its
targets. To investigate this hypothesis in vivo, we inactivated
Brg137 in SHF progenitor cells using an Isl1-Cre driver line. Brg1-
deficient embryos showed a shortened outflow tract, a small right
ventricle at E9.5 and died by E14.5 (Fig. 5f–h). Immunohistochem-
ical stainings and qPCR expression analysis of dissected OFT
and RV of E10.5 wild-type, Isl1-Cre+/−, Isl1-Cre+/−/Brg1fl/+ and Isl1-
Cre+/−/Brg1fl/fl embryos revealed significant downregulation of Isl1
primary targets in Isl1-Cre+/−/Brg1fl/+ embryos and further
decrease in Brg1-deficient embryos (Fig. 5h, i), whereas no major
changes were observed in the left ventricles of these embryos
(Supplementary information, Fig. S5b) or in the expression of
genes, that are not Isl1 targets, in the right ventricle (Supplemen-
tary information, Fig. S5c). The dosage-sensitive interdependence
of Isl1 and Brg1 supports the hypothesis that the Brg1-Baf60c
complex might regulate gene expression in concert with Isl1. We
next examined whether Brg1 was directed to Isl1 target sequences
via Isl1. Knockdown of Isl1 led to a significant reduction of Brg1
occupancy at Isl1 targets (Fig. 5j), suggesting that Isl1 might recruit
the Brg1 complex to promote chromatin reorganization at its
target genes.
Baf60c mediates interactions between cardiac transcription
factors such as Tbx5, Nkx2-5, Gata4 and the Brg1 complex to drive
cardiac specific gene expression.19–21 To test whether Baf60c
promotes the binding of Isl1 to the Brg1 complex, we performed
co-immunoprecipitation in control and Baf60 KD ESC-derived CPCs
using Isl1 antibody. Similar binding of Isl1 and Brg1 was observed
in control and Baf60-depleted CPCs suggesting that, in contrast to
Tbx5, Nkx2-5 and Gata4, Baf60c does not mediate the association
of Isl1 with the Brg1 complex (Fig. 5k). Consistent with a role of Isl1
in not only regulating Baf60c levels but also working together with
the Brg1-Baf60c complex, overexpression of Baf60c was not
sufficient to rescue the cardiac differentiation defect of Isl1
knockdown ESC and the expression of Isl1-Baf60c target genes
(Supplementary information, Fig. S5d, e).
Isl1 acts as a pioneer factor in cardiogenesis
Pioneer transcription factors play critical roles in programming the
epigenome and instructing lineage specification and
differentiation.1,2,4 To initiate cell programming pioneer transcrip-
tion factors engage “closed” chromatin covered by nucleosomes.
To test whether Isl1 could bind to DNA wrapped around
nucleosomes we performed in vitro electrophoretic mobility shift
assays (EMSAs). For the analysis we selected a DNA probe
containing Isl1 motifs within the Ttn promoter region, which was
bound by Isl1,38 and downregulated in Isl1 and Baf60c depleted
CPCs. As expected, recombinant Isl1 (Supplementary information,
Fig. S6a) bound to the free DNA probe within Ttn promoter region
(Fig. 6a, lanes 1-6). Next, we assembled the Ttn-DNA into
nucleosomes by salt gradient dilution assembly with recombinant
human histones (Supplementary information, Fig. S6b, c). Impor-
tantly, Isl1 showed similar binding to DNA assembled in
nucleosomes compared to free DNA (Fig. 6b, lanes 7–12).
Competition assays using a 80-fold molar excess of specific
competitor DNA probe containing Isl1 binding sites, but not probe
containing non-specific sequences, supported the specific binding
of Isl1 to free Ttn-DNA and Ttn-DNA assembled into nucleosomes
(Fig. 6b). In contrast, Nkx2.5 bound free Ttn DNA but was not able
to bind Ttn-DNA assembled into nucleosomes (Supplementary
information, Fig. S6d).
Pioneer factor binding imparts competence for transcription by
chromatin opening. To further test whether Isl1 acts as a pioneer
factor, we analyzed whether Isl1 binding might induce the
formation of accessible chromatin in CPCs by performing
genome-wide analysis of open chromatin landscapes using ATAC
(‘assay for transposase-accessible chromatin’) sequencing (ATAC-
Seq)39 in mESC-derived CPCs (Supplementary information,
Table S7). Comparison of ATAC-Seq data and Isl1 binding profiles
revealed a 42% overlap of Isl1 ChIP-Seq with ATAC-Seq peaks in
CPCs. At the promoter proximal regions (TSS±10 kb) 76% of Isl1
binding sites showed open chromatin (Fig. 6c, d), suggesting a
Fig. 3 Isl1 orchestrates a complex gene regulatory network driving cardiogenesis. a, b Heatmap representation of RNA-Seq analysis of
dissected pharyngeal mesoderm and hearts of wild-type and E8.75 Isl1 knockout embryos (a) as well as dissected OFT and RV of E10.5 wild-
type and Isl1 hypomorphic embryos (n= 4, fold change >1.5; log2 fold change <−0.58, >0.58; p-value < 0.05) (b). GO terms enriched among
genes downregulated or upregulated upon Isl1 loss-of-function and representative genes within these GO terms are presented on the right
side of the panel. c Venn diagram representing the overlap of genes bound by Isl1 in E8.25-E9 embryos or ESC-derived CPCs (n= 2) and
differentially expressed in dissected pharyngeal mesoderm/ hearts of E8.75 Isl1 knockout embryos as well as OFT and RV of E10.5 Isl1
hypomorphic embryos compared to control embryos (n= 4). d Isl1-regulated gene network identified using GeneMANIA and Cytoscape.
e–g GO terms enriched in genes bound by Isl1 in ESC-derived CPCs or E8.25-E9 embryos and deregulated in E8.75 Isl1 knockout embryos (e),
in E10.5 OFT+RV of Isl1 hypomorphic embryos (f), or in both E8.75 Isl1 knockout embryos and E10.5 OFT+RV of Isl1 hypomorphic embryos (g).
Examples of genes regulated and bound by Isl1 in (e–g), showing genome tracks of Isl1 ChIP-Seq in CPCs and RNA-Seq reads, are presented
on the right side of the panel
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role of Isl1 binding in the formation of accessible chromatin
required for cardiogenesis, similar to other “pioneer factors”. The
core cardiac transcription factor GATA4 represents a prototypical
example of a pioneer factor, it binds efficiently to its target
sequences on nucleosomal DNA40 and induces chromatin
reorganization driving heart development and disease.41 To
address whether GATA4 binding might affect Isl1 binding or vice
versa, we first compared GATA45 and Isl1 binding sites in CPCs
with ATAC-Seq peaks. Using the published GATA4 ChIP-exo
average footprints5 (footprints present in at least two replicates),
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we observed 232 sites that were bound by GATA4 and Isl1 that
showed accessible chromatin, whereas 5628 Isl1 ChIP-Seq peaks
overlapped with ATAC-Seq peaks (Supplementary information,
Fig. S6e). Heatmap analysis, however, showed relatively high
GATA4 signal at Isl1-ATAC only sites, suggesting dynamic GATA4
binding (Supplementary information, Fig. S6f). Therefore, we
called peaks in each GATA4 ChIP-exo replicate and used high
confidence peaks found in all three ChIP-exo replicates for further
analysis. This analysis identified 2417 common Isl1-GATA4-ATAC
peaks, showing that Isl1 and GATA4 often co-occupy sites
characterized with open chromatin (Fig. 6e, f). In addition, we
identified accessible chromatin sites bound only by Isl1 or GATA4,
supporting the notion that Isl1, similar to GATA4, functions as a
pioneer transcription factor (Fig. 6e, f).
Finally, we analyzed whether loss of Isl1 or Brg1 might affect
chromatin opening by performing ATAC-Seq in E8.75 (6 somites)
wild-type, Isl1−/− or Isl1-Cre+/−/Brg1fl/fl embryos (Supplementary
information, Table S8). We observed 73% overlap of all ATAC-Seq
peaks in pharyngeal mesoderm and hearts of E8.75 embryos
compared to ESC-derived CPCs (Fig. 7a) whereas we observed
93% overlap at promoter proximal regions (TSS±10 kb, Fig. 7a)
showing high similarity between the open chromatin of in vitro
differentiated CPCs to CPCs in early embryos. Importantly, we
observed significant reduction of chromatin accessibility at Isl1-
ATAC peaks (i.e. sites bound by Isl1 showing open chromatin
conformation) upon Isl1 and Brg1 loss (Fig. 7b, c), whereas
chromatin accessibility was not affected at ATAC only sites (not
bound by Isl1). Reduction in chromatin accessibility was observed
in both Isl1-ATAC sites bound or not bound by GATA4 (IGA or IA
only), supporting the notion that Isl1 acts as pioneer factor also
independently of GATA4 (Fig. 7d). In addition, GATA4 binding was
decreased in Isl1 depleted CPCs (Supplementary information,
Fig. S7a). However, we cannot pinpoint whether Isl1 is necessary
for GATA4 association at Isl1 target sites or whether lower GATA4
occupancy could be due to the decreased levels of GATA4 in Isl1-
deficient CPCs (Fig. 4d, Supplementary information, Table S5). In
addition, the high average ATAC signal at Isl1-ATAC sites
compared to ATAC only sites further supports a role of Isl1 in
chromatin opening in CPCs (Fig. 7c). GO analysis of differential
ATAC-Seq peaks in Isl1 and/or Brg1-deficient embryos revealed
that the Isl1/Brg1 complex plays a key role in activating the
expression program essential for heart development while
repressing nervous system development and cell adhesion (Fig. 7e,
Supplementary information, Fig. S7b). Importantly, we observed
significant overrepresentation of GO terms related to chromatin
modification in ATAC-Seq peaks decreased in Isl1 knockout
embryos, including multiple components of the SWI/SNF chro-
matin remodeling complexes such as Arid1a (Baf250), Pbrm1
(Baf180); Dpf3 (Baf45c), Smarcd3 (Baf60c) as well as Brg1/Smarca4
(Fig. 7f, Supplementary information, Fig. S7c, Table S7). Genes
showing decreased chromatin accessibility only in Isl1 knockout
embryos mostly encoded factors involved in transcriptional
regulation, suggesting that Isl1 might work together with other
chromatin modifiers to regulate their expression (Supplementary
information, Fig. S7c). Genes not bound by Isl1 did not show
changes in chromatin accessibility (Supplementary information,
Fig. S7c). In a complementary approach, we observed an increase
of H3 occupancy at Isl1/Brg1-Baf60c targets in Isl1 and Baf60c
knockdown CPCs compared to control CPCs (Supplementary
information, Fig. S7d). Isl1-positive cardiovascular progenitors are
multipotent and can differentiate into all three cardiovascular
lineages: cardiomyocytes, smooth muscle cells and endothelial
cells.14 Analysis of chromatin accessibility at promoters of cardiac,
smooth muscle and endothelial development/differentiation
genes revealed a decrease in open chromatin at all cardiovascular
lineage-related genes in Isl1 and Brg1-deficient embryos (Supple-
mentary information, Fig. S8). Notably the ATAC-Seq signal was
highly decreased at genes involved in cardiac contraction.
Nevertheless, these data suggest that Isl1 might play a pioneering
function not only for cardiomyocytes but also for other
cardiovascular lineages and that it requires the Brg1-based SWI/
SNF chromatin remodeling complex.
Taken together these data suggest a pioneering function of Isl1
by binding to inaccessible chromatin and working in concert with
the Brg1-Baf60c-based SWI/SNF complex to confer permissive
lineage-specific alterations in CPC chromatin landscape. These
allow gene expression directly in CPCs or at a later time point in
cardiomyocytes (Fig. 7g).
DISCUSSION
Pioneer transcription factors play critical roles in programming the
epigenome during lineage specification.1–4 Our study shows that
Isl1 acts as a pioneer transcription factor in heart development by
shaping the chromatin landscape in CPCs and orchestrating a
complex gene regulatory network driving cardiac development
and defining cardiomyocyte identity. Similar to other well-
characterized pioneer factors, such as forkhead box A (FOXA)
factors, GATA-binding (GATA) factors, PU.14 and the pluripotency
factors OCT4, SOX2 and KLF4,1 Isl1 recognizes its DNA binding
motif even when the DNA is wrapped around nucleosomes, which
enables it to engage its target sites even in condensed chromatin.
ATAC-Seq of ESC-derived CPCs and CPCs in embryos revealed that
open chromatin regions are centered on Isl1 binding sites and loss
of Isl1 led to significant decrease of chromatin accessibility,
suggesting an important role of Isl1 binding in the formation of
accessible chromatin. We further show that Isl1 works in concert
with the Brg1-based SWI/SNF complex to promote chromatin
accessibility and establish competence for lineage specific gene
activation.
Using an Isl1 hypomorphic mouse line, genome-wide profiling
of Isl1 binding together with RNA- and ATAC-sequencing of
cardiac progenitor cells and their derivatives, we uncover a
regulatory network downstream of Isl1 that orchestrates cardio-
genesis (Fig. 3d). We show that Isl1 binds to and regulates the
expression of transcription factors, epigenetic modifiers and
signaling molecules with critical functions and high expression
in SHF CPCs.8,10 An important group of Isl1 target genes play key
Fig. 4 Baf60c is a key Isl1 downstream target. a Scheme depicting distinct stages of directed cardiac differentiation (top). Relative mRNA
expression of selected cardiomyocyte contraction and structural genes at day 10 of cardiac differentiation after Isl1 KD at day 4 (left panel) or
at day 8 (right panel). Data are presented as mean ± SEM, n= 3. b Heatmap representation of RNA-Seq analysis of FACS-sorted Nkx2-5+ CPCs
derived from wild-type and Isl1−/− ESCs (n= 2; fold change >1.5; log2 fold change <-0.58, >0.58; p-value < 0.05). c Overlap between genes
bound by Isl1 in mESC-derived CPCs and differentially expressed in sorted Isl1−/− compared to control CPCs. d Examples of genes regulated
and bound by Isl1 in mESC-derived CPCs, showing genome tracks of Isl1 ChIP-Seq and RNA-Seq reads of sorted control and Isl1−/− mESC-
derived CPCs. e GO terms enriched in genes bound by Isl1 in mESC-derived CPCs and downregulated in Isl1 knockout CPCs. f WT and Isl1
knockout E9.5 embryos viewed from the left (left panels) and the right (right panels) after in situ hybridization with a Baf60c probe. Scale bars,
200 µm. Abbreviations: rv, right ventricle; lv, left ventricle; OFT, outflow tract. g Heatmap representation of RNA-Seq analysis of FACS-sorted
Nkx2-5+ CPCs derived from control and Baf60c knockdown mESCs (n= 2; fold change >1.5; log2 fold change <−0.58, >0.58; p-value < 0.05).
h Overlap of deregulated genes in sorted Isl1−/− and Baf60c knockdown CPCs. i Heatmap of genes downregulated or upregulated in both Isl1
knockout and Baf60c knockdown versus control CPCs. Representative genes and enriched GO terms are presented on the right side
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roles in development of the atrioventricular canal and in outflow
tract morphogenesis, including Wnt2/5/11, Tgfb2, Jag1, Maml1,
Smad6, Pbx3, Msx2, Fog2 (Zfpm2), Tbx3/5/20, and Plxna2.42
Consistent with this we observed various degrees of cardiac
outflow tract septation abnormalities, including partial outflow
tract septation and misalignment or common arterial trunk,
ventricular septal defects and atrial septal defects in Isl1
hypomorphic mouse embryos. Similarly, genetic variations in
ISL1 have been associated with susceptibility to ventricular septal
defect43 and non-syndromic, complex congenital heart disease17
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in human patients, whereas ISL1 haploinsufficiency is associated
with d-transposition of the great arteries.16 Thus, our Isl1
hypomorphic mouse model represents a valuable genetic system
to gain new insights into the etiology of congenital heart defects
and for developing novel therapeutic strategies.
While Isl1 binding to genes with critical functions and high
expression in SHF CPCs might have been expected, it was
surprising to see that Isl1 binds to cardiomyocyte structural
genes and genes involved in cardiomyocyte function in CPCs
well before these genes are highly expressed in differentiating
cardiomyocytes. Consistent with this, loss of Isl1 was associated
with significantly reduced expression of cardiomyocyte struc-
tural genes and genes involved in cardiac contraction and
sarcomerogenesis that were bound by Isl1 in CPCs. This suggests
that Isl1 directly controls cardiomyocyte identity, CPC differ-
entiation and sarcomeric maturation. We reason that Isl1 binds
to closed chromatin and spawns permissive cardiomyocyte
lineage-specific alterations in the chromatin landscape of CPCs,
which enables subsequent recruitment of additional regulatory
factors activating these genes in cardiomyocytes when Isl1 itself
is switched off. Thus, this establishes a lasting regulatory
network driving cardiogenesis. We did not observe any change
in the expression of Isl1 primary target genes in the left ventricle
of Isl1 hypomorphic embryos whereas they were significantly
changed in dissected right ventricles, suggesting a specific role
of Isl1 in the second heart field. However, we found a strong
decrease of Baf60c in the left ventricle of Isl1 knockout embryos.
In addition, other studies have also observed downregulation of
Isl1 targets in the whole hearts of Isl1 knockouts.9,12 Since Isl1
has been reported to be transiently expressed in CPCs of the first
heart field, we cannot exclude a possibility that Isl1 plays a
pioneer role in the first heart field. In addition, analysis of
chromatin accessibility at promoters of cardiac, smooth muscle
and endothelial development/differentiation genes revealed a
decrease in open chromatin at all cardiovascular lineage-related
genes in Isl1 and Brg1-deficient embryos, suggesting that Isl1
may also play a pioneering role for cardiac endothelial cell
lineage settlement. This is consistent with single cell analyses
demonstrating the critical role of Isl1 in cardiovascular
progenitor fate bifurcation into the endothelial and cardiomyo-
cyte lineages.44
We demonstrate that Isl1 works together with the Brg1-Baf60c
complex to induce chromatin reorganization at its target sites and
promote cardiac differentiation. Consistent with this, depletion of
either Isl1, Brg1 or Baf60c led to a significant decrease of
chromatin accessibility at Isl1 target genes and depletion of Brg1
in Isl1+CPCs led to defects in cardiac morphogenesis, cardio-
myocyte differentiation and the expression of Isl1 primary
downstream targets. The key importance of the Brg1-based
SWI/SNF complex in heart development is also evidenced by
genetic studies in mice, showing that Brg1 haploinsufficiency
leads to various cardiac morphogenetic defects.19 A large body of
studies has demonstrated that the SWI/SNF complexes undergo
progressive changes in subunit composition during develop-
mental transitions and that the unique subunit composition at
each developmental stage correlates with a gene expression
program that is required for maintaining a particular cell state.45–
47 Similarly, the inclusion of distinct BAF subunits promotes
temporally distinct gene expression programs in cardiogenesis.36
Interestingly, we found a significant decrease of chromatin
accessibility at multiple components of the SWI/SNF chromatin
remodeling complexes such as Arid1a (Baf250), Dpf3 (Baf45c),
Smarcd3 (Baf60c) as well as Brg1 (Smarca4) in Isl1 knockouts and
decreased expression in CPCs or Isl1 hypomorphic and Isl1
knockout embryos, suggesting a mechanism by which Isl1
reinforces its function in chromatin reorganization to drive
cardiogenesis. Ablation of BAF250a, a critical regulatory subunit
in the SWI/SNF BAF complex, in the SHF using Mef2c-Cre leads to
persistent truncus arteriosus, trabeculation defects, reduced
cardiomyocyte proliferation and differentiation, and embryonic
lethality around E13, similar to our data from ablation of Brg1
with Isl1-Cre. The cardiac-specific subunits of the complex, Baf45c
and Baf60c, also play instrumental roles during cardiogenesis and
cardiomyocyte differentiation.20,48,49 The Brg1-Baf60c activity was
shown to direct ectopic differentiation of mouse non-cardiogenic
mesoderm into beating cardiomyocytes in concert with Gata4
and Tbx5 by permitting the binding of Gata4 to cardiac specific
genes.21 We found that Baf60c together with Isl1 is required for
the activation of genes involved in cardiomyocyte contraction,
sarcomere organization and transcriptional regulation, whereas
Baf60c alone activates genes participating in ion transport. This is
consistent with the gene expression changes observed in Baf60c
knockout embryos.49 During cardiogenesis, Baf60c mediates
interactions between the core cardiac transcription factors Tbx5,
Nkx2-5, Gata4 and the Brg1 complex.19–21 In contrast, Baf60c does
not seem to moderate Isl1 binding to the Brg1 complex. However,
the loss of Baf60c upon Isl1 depletion may additionally affect the
function of Tbx5, Nkx2-5 and Gata4, as an imbalance between
their levels and the Brg1-Baf60c complex was shown to result in
impaired cardiac development and transcriptional activation of
their targets.19
Given that a set of transcription factors can induce direct or
partial reprogramming via CPCs of non-myocyte cells into
functional cardiomyocytes,50–52 it is of utmost interest to find
the optimal set of factors and understand how their activities
could be enhanced to improve cell reprogramming for clinical
applications. Although many cocktails of regulatory factors have
been employed in direct cardiac reprogramming, the resultant
cells often are immature and/or incompletely specified and the
efficiency is low. It has been suggested that a transition through
an early lineage intermediate, in which pioneer transcription
factors of cell fate can engage naïve chromatin to induce
hierarchical lineage specific regulatory networks, may improve
the efficiency of reprogramming.53 The discovery of Isl1 as a
pioneering factor in cardiogenesis can help to develop more
efficient strategies for cardiac reprogramming.
Fig. 5 Isl1 works in concert with the Brg1 SWI/SNF complex to regulate its target gene expression. a Co-immunoprecipitation showing
interaction between Isl1 and Brg1 in E8.25-E9 embryos. b Examples of genes bound by Isl1 and Brg1, showing genome tracks of Isl1 ChIP-Seq
and Brg1 ChIP-Seq reads. c Venn diagram representing the overlap of all Isl1 and Brg1 ChIP-Seq peaks36 (top) or of peaks at Transcription Start
Sites (TSS)+/− 10 kb (bottom). P value was calculated with Fisher’s exact test. Only high confidence peaks, found in the two ChIP-Seq
replicates, were used in the analysis. d Average Isl1 and Brg1 ChIP-Seq tag intensities at Isl1 peaks. (e) Venn diagram representing the overlap
of genes bound by Isl1 and Brg1 (n= 2) and differentially expressed in Isl1−/− CPCs (n= 2). f Control and Isl1-Cre+/−/Brg1fl/fl E9.75 embryos
viewed from the right. Scale bars, 500 µm. g Histological analyses of control and Isl1-Cre+/−/Brg1fl/fl E10.5 embryos. Scale bars, 500 µm.
h Immunostaining of right ventricles of control and Isl1-Cre+/−/Brg1fl/fl E11.5 hearts for Mlc1v. Scale bar, 50 µm. i Relative mRNA expression
levels of Isl1/Brg1 common targets in dissected OFT and RV of wild-type, Isl1-Cre+/−, Isl1-Cre+/−/Brg1+/fl and Isl1-Cre+/−/Brg1fl/fl E10.5 embryos.
Data are mean ± SEM, n= 4. j ChIP-qPCR to analyze Brg1 occupancy at Isl1 bound sequences in control and Isl1 KD CPCs. Atp1a2, a gene not
bound by Isl1, serves as a negative control. k Co-immunoprecipitation with anti-Isl1 antibody and Western blot analysis for Brg1 in control or
Baf60c KD CPCs, showing that the interaction between Isl1 and Brg1 does not depend on Baf60c
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Fig. 6 Isl1 recognizes its DNA binding motif on DNA wrapped around nucleosomes and its binding correlates with sites of open chromatin.
a EMSA with increasing amount of recombinant Isl1 protein (0, 0.2, 0.4, 0.6, 0.8 and 1 µM) and free Ttn DNA fragment harbouring Isl1 binding
sites (left panels) and the same fragment assembled into nucleosomes (right panels). b Competition assay showing the specificity of Isl1
binding to free and nucleosomal Ttn DNA using specific Isl1 binding oligo and nonspecific oligo as competitors at 80× molar ratio excess. S,
specific competitor; NS, nonspecific competitor. c Overlap of all Isl1 ChIP-Seq and ATAC-Seq peaks (top; n= 2, each) or peaks at Transcription
Start Sites (TSS)±10 kb in mESC-derived CPCs. Only high confidence peaks, found in two Isl1 ChIP-Seq and ATAC-Seq replicates, were used in
the analysis. d Examples of genes bound by Isl1, showing open chromatin configuration at Isl1 binding sites in mESC-derived CPCs. Genome
tracks of Isl1 ChIP-Seq and ATAC-Seq reads of mESC-derived CPCs. e Overlap of all Isl1 ChIP-Seq (n= 2), GATA4 ChIP-exo5 (n= 3) and ATAC-Seq
peaks (n= 2) (top) or peaks at Transcription Start Sites (TSS)±10 kb in CPCs. f Heatmap (top) and aggregation plot (bottom) of mapped reads
of Isl1 ChIP-Seq, GATA4 ChIP-exo and ATAC-Seq at 2 kb around peak midpoints of Isl1, GATA4 and ATAC (IGA); Isl1 and GATA4 (IG); Isl1 and
ATAC (IA); GATA4 and ATAC (GA) occupancy groups
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In conclusion, our study highlights a pioneering function of Isl1
in cardiac lineage commitment and provides exciting novel
insights into the molecular machinery orchestrating cardiogenesis.
MATERIALS AND METHODS
All animal experiments were done in accordance with the Guide
for the Care and Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication No. 85-23, revised
1996) and according to the regulations issued by the Committee
for Animal Rights Protection of the State of Hessen (Regierung-
spraesidium Darmstadt) and of the Tongji University School of
Medicine (TJmed-010-10).
Histology
Embryos were sacrificed by cervical dislocation and hearts were
isolated and fixed with 4% paraformaldehyde overnight at 4 °C.
After fixation the hearts were dehydrated in ethanol and stored at
−20 °C for further paraffin embedding, sectioning and H&E
staining. For histological analysis hearts were incubated in xylol
and embedded in paraffin. Hematoxylin and eosin staining was
performed according to the manufacturer’s instruction (Sigma,
GHS116, HT-110216). Representative images of histological
analysis of minimum six embryos with the same genotype are
presented.
Magnetic resonance imaging (MRI)
Embryos were analyzed by MRI, as previously described.54 Briefly,
paraformaldehyde-fixed embryos were embedded in a MRI
contrast agent and imaged using an 11.7 Tesla magnet. The 3D
MRI dataset obtained was reconstructed into axial TIFF slices.
Image datasets were analyzed and 3D reconstructions created
using Amira 3.0 software.
Immunofluorescence and imaging
Paraffin sections were de-paraffinized and re-hydrated. Heat-
induced epitope retrieval was performed in 10 mM sodium citrate,
pH 6.0. Sections were blocked for 1 h (10% fetal bovine serum in
1× PBS+0.5% Triton X-100) followed by incubation with anti-
myosin heavy chain antibody 1:50 dilution (MF20, DSHB) and
Mlc1v (Santa Cruz, SC-47719) overnight at room temperature.
Sections were washed three times in 1× PBS/0.5% Triton X-100 for
10min and incubated with respective secondary antibodies, e.g.,
anti-mouse Alexa 594 (Thermo Fisher Scientific, A11005), anti-
rabbit Alexa 488 (Thermo Fisher Scientific, A21206) along with
DAPI for 1 h at room temperature. 50% glycerol was used for
Fig. 7 Isl1 and the Brg1-based SWI/SNF complex shape the chromatin landscape at Isl1 targets in CPCs. a Overlap of all ATAC-Seq peaks in
ESC-derived CPCs (n= 2) and pharyngeal mesoderm/hearts of E8.75 embryos (n= 3) (top) or peaks at Transcription Start Sites (TSS)±10 kb
(bottom). Only high confidence peaks, found in the two ATAC-Seq replicates of ESC-derived CPCs or in the three ATAC-Seq triplicates of E8.75
embryos, were used in the analysis. b Heatmap of tag densities of ATAC-Seq signal in wild-type, Isl1−/− and Isl1-Cre+/−Brg1fl/fl embryos at top
1000 Isl1-ATAC (IA) or ATAC only (A) peaks. c Average ATAC-Seq tag intensities in wild-type, Isl1−/− and Isl1-Cre+/−Brg1fl/fl embryos at Isl1-ATAC
(IA) or ATAC only (A) peaks. d Average ATAC-Seq tag intensities at common peaks between Isl1, GATA4 and ATAC-Seq in wild-type, Isl1−/− and
Isl1-Cre+/−Brg1fl/fl embryos (left) or at Isl1 and ATAC-Seq only peaks. e GO terms enriched in ATAC-Seq peaks decreased (top panel) or increased
(lower panel) more than 2 fold (p < 0.05) in Isl1−/− versus control embryos. f Examples of genes showing decreased ATAC-Seq signal at Isl1
binding sites. Genome tracks of Isl1 ChIP-Seq and ATAC-Seq of wild-type, Isl1−/− and Isl1-Cre+/−Brg1fl/fl embryos are presented. g Model of the
role of Isl1 in cardiogenesis by controlling epigenetic mechanisms and memory. Isl1 binds to compacted chromatin at genes involved in CPC
function, as well as to genes involved in cardiomyocyte contraction and structural organization. Isl1 works in concert with the Brg1-Baf60c-
based SWI/SNF complex to open up chromatin and allow gene expression directly in CPCs, or at a later time point in cardiomyocytes
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mounting and image acquisition was done using a Zeiss LSM 710
confocal microscope. Representative images of immunostainings
of three embryos with the same genotype are presented.
ES Cell culture and differentiation
E14 Tg(Nkx2–5-EmGFP) ES cells55 were maintained on mitomycin
treated mouse embryonic fibroblasts (MEF) in Knockout DMEM
medium (GIBCO, 10829018) containing 4.5 mg/ml D-glucose,
supplemented with 10% serum replacement (GIBCO, 10828028),
2 mM L-Glutamine, 0.1 mM 2-mercaptoethanol (Sigma, M3148), 1
mM sodium pyruvate (GIBCO, 11360039), and 1,000 U/ml of
leukemia inhibitory factor (ESG1107, Millipore). ES cells were
differentiated in cardiomyocytes either by the standard hanging
drop method56 or by directed differentiation of ES cells into
cardiomyocytes according to the protocol described in.29 Briefly,
for directed cardiomyocyte differentiation ES cells were grown on
gelatin in Neurobasal medium: DMEM/F12 (1:1; GIBCO, 21103049
and 21331020) medium supplemented with 2000U/ml LIF and 10
ng/ml BMP4 (R&D, 314-BP) for 2 days and differentiated by
aggregation in low attachment bacterial dishes at a cell density of
75000 cells/ml in IMDM: F12 medium (3:1; GIBCO, 12440053 and
11765054). After 48 h aggregates were dissociated and re-
aggregated in the presence of Activin A (R&D, 338-AC; 5 ng/ml),
VEGF (R&D, 293-VE-010; 5 ng/ml) and BMP4 (R&D, 314-BP; 0.1-0.8
ng/ml; Bmp4 concentration was empirically determined depend-
ing on lot). 40 h following the second aggregation, aggregates
were dissociated and plated as a monolayer in Stempro-34
medium supplemented with Stempro34 nutrient supplement
(GIBCO, 10639011), L-Ascorbic Acid (A4403 Sigma) and VEGF
(R&D #293-VE-010; 5 ng/ml), bFGF (R&D, 233-FB; 10 ng/ml), and
FGF10 (R&D, 345-FG; 25 ng/ml) growth factors. We usually
obtained around 60-80% of Nkx2.5-GFP+CPCs using this protocol.
Nkx2.5-GFP positive cells were FACS sorted at day 5 CPC stage for
RNA extraction.
ES cell differentiation by the standard hanging drop method
was induced by dissociating ES cells and aggregating 500 cells in
15 µl drops in ES cell growth medium without LIF. After 48 h in
hanging drops the resulting EBs were transferred to low
attachment culture dishes. At day 5, EBs were dissociated and
CPCs were FACS sorted for GFP expression.
For stable transfections HEK293T cells were seeded on a 6-well
plate and were transfected at 50%–80% confluency with 3 µg of
plasmids containing shRNA for Baf60c (Sh1: CGCCTAAAGTTCTCTGA-
GATT, Sh2: GCTGCGCCTTTATATCTCCAA), Isl1 (CGGCAATCAAATTCAC-
GACCA) or control (pLKO) along with packaging and envelope
plasmids obtained from the RNAi consortium (TRC) shRNA library
using using X-tremeGENE DNA transfection reagent (Roche,
6366236001). 48 h after transfection the viral supernatant was
collected and used to transduce 100.000 ES cells on 5% poly-
HEMA (Sigma, P3932) treated plates for 12 h. The following day, the
transduced ES cells were plated on feeders and 24 h after
transduction were selected with 10 ng/mL puromycin for 2 passages.
For generation of Isl1−/− ESCs by CRISPR/Cas9-mediated gene
targeting, a combination of two guide RNAs (gRNAs) was used as
follows: gRNA-1: 5′- CCGATTTAAGCCGGCGGAGT -3′ and gRNA-2:
5′- TCATGAGCGCATCTGGCCGA -3′. pSpCas9(BB)-2A-Puro (PX459)
V2.0, kind gift from Feng Zhang (Addgene plasmid # 62988,57) was
digested and ligated with annealed gRNAs into the recombinant
plasmid pSpCas9(BB)-2A-Puro-gRNA-1 and pSpCas9(BB)-2A-Puro-
gRNA-2. Both plasmids were transfected into ESCs using
Lipofectamine 2000 according to the manufacturer’s protocol.
Positive cells were selected after 24 h for 48 h using puromycin
(4 µg/ml) and 5, 000 cells were further plated in a 6-cm dish. After
7 days of culture, single clones were picked and screened by PCR.
RNA isolation and qRT-PCR analysis
RNA was isolated using TRIzol (Invitrogen, 15596026) or RNeasy
mini kit (QIAGEN, 73304) following the manufacturer’s instructions
and cDNA synthesis was performed using High-capacity cDNA
reverse transcription kit and random primers (Applied Biosystems,
4368813). Gapdh or Actc1 (where specified in the figure legends)
were used for normalizing gene expression.
In situ hybridization
Embryos were fixed overnight at 4 °C in 4% PFA followed by
dehydration in methanol. For in situ analysis, embryos were
rehydrated and treated with proteinase K (10 µg/ml) for 12 min
and re-fixed in 4% PFA, followed by incubation overnight at 65°C
with DIG-labeled Baf60c RNA probe in hybridization buffer
containing 50% formamide, 5 x SSC, 1% SDS, 5 µg/µl yeast tRNA
and 10 µg/µl heparin. Next, the embryos were washed two times
with 50% formamide, 5 x SSC, 1%SDS followed by subsequent
washes in 2 × SSC and 0.2 x SSC at 65 °C and 1xMABT (100 mM
maleic acid, 150 mM NaCl). Embryos were treated with 2×
blocking reagent (Roche, 11096176001) for 2 h at room tempera-
ture followed by incubation with alkaline phosphatase conjugated
anti-DIG antibody (Roche, 11093274910) for 18 h at 4 °C. For color
development BM-purple reagent (Roche, 11442074001) was used.
Representative image of three control and three Isl1 knockout
embryos were presented.
Co-immunoprecipitation
For co-immunoprecipitation cardiac progenitor cells differentiated
from mouse ES cells and 30 mouse embryos (E8.25-E9) homo-
genized with plastic pestle were lysed with lysis buffer (50 mM Tris
pH 7.5, 10 mM EGTA, 100mM NaCl, 0.1% Triton X-100) plus
protease and phosphatase inhibitors on ice. After sonication and
centrifugation, the supernatant was used for immunoprecipita-
tion. Embryoid bodies were trypsinized to obtain a single cell
suspension. Nuclei were isolated by incubating in lysis buffer
containing 50mM Tris pH 8.0, 2 mM EDTA pH 8.0, 0.1% NP-40,
10% glycerol along with protease and phosphatase inhibitors.
Isolated nuclei were disrupted by sonication in 50 mM Tris pH 8.0,
0.1% SDS, 5 mM EDTA pH 8.0 buffer along with protease and
phosphatase inhibitors. 500 µg of protein lysates were precleared
with Protein G-Sepharose beads (GE Healthcare, 17-0618) at 4 °C
on a rotary shaker for 1 h. Precleared lysates were incubated with
1 µg of α-Isl1 antibody (39.4D5 DSHB) overnight at 4 °C. Protein
complexes were bound to Protein G-Sepharose beads for 1 h at
4°C. Protein complex bound beads were washed and resolved in a
standard SDS-PAGE system. Brg1 (1:500, Santa Cruz, SC-10768), Isl1
(1:10 dilution; 39.4D5 DSHB) and Baf60c antibody (1 to 500
dilution; a kind gift from Pier Lorenzo Puri) were used for western
blotting.
RNA-Sequencing
Pharyngeal mesoderm/ hearts of E8.75 (6 somites) and OFT+RV of
E10.5 control and Isl1 KO or hypomorphic embryos were dissected
and stored at −80 °C in Qiazol. Total RNA from single embryos was
extracted using Rneasy Microarray Tissue Kit (Qiagen #73304).
Control, Baf60c KD and Isl1 KO Nkx2.5-GFP ES cell lines were
differentiated into cardiac progenitors. Nkx2.5-GFP positive cells
from two different control and Isl1−/− clones or control and Baf60
KD ESCs pools were sorted and RNA was isolated using RNeasy
microarray kit (Qiagen #73304). The integrity of RNA was assessed
on Bioanalyzer 2100 (Agilent). For RNA-Seq of control, Isl1
hypomorphic and Isl1−/− tissue samples, 100 ng of total RNAs
was used for library preparation and sequenced on BGISEQ-500 or
on NextSeq500 (Illumina), respectively. For RNA-Seq of control,
Isl1−/− and Baf60c KD CPCs, 1 µg RNA was used as input for Truseq
Stranded mRNA library preparation (Illumina). Sequencing was
performed on NextSeq500 (Illumina) using V2 chemistry.
RNA-Seq data analysis
RNA-Seq reads were mapped to the mm9 reference genome using
STAR58 (−alignIntronMin 20 −alignIntronMax 500000). Samples
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were quantified using analyzeRepeats.pl59 (mm9 –count exons –
strand both –noadj). Differential expression (fold change >1.5;
log2 fold change <−0.58, >0.58; p-value < 0.05) was quantified
and normalized using DESEq2. Reads per kilobase per millions
mapped (rpkm) was determined using rpkm.default from EdgeR.
The KNIME 2.9.1 platform (Konstanz, Germany) was used to filter
differentially regulated genes. Gene ontology analysis was
performed using DAVID Bioinformatics Resources 6.8. Heatmaps
from the RNA-Seq were created using heatmap.2 from ggplot2 in
R. Values in the heatmaps represent Z-score calculated from
(Log2RPKM+1) after row normalization. The PCA plots in each
RNA-Seq dataset were obtained using rowVars and prcomp into a
custom R-script.
Chromatin immunoprecipitation (ChIP) and ChIP sequencing
Mouse embryos at E8.25-E9 were collected into cold PBS.
Cardiogenic mesoderm and heart region was crosslinked with
1% formaldehyde at room temperature for 15 min, whereas mESC-
derived CPCs for 10 min. Crosslinking was terminated by adding
125mM glycine followed by three washes with cold PBS. Single
cells were obtained by disruption of the tissue using pestle and
mortar and nuclei were isolated by incubation in lysis buffer (50
mM Tris pH 8.0, 2 mM EDTA pH 8.0, 0.1% NP-40, 10% glycerol)
along with protease and phosphatase inhibitors. Nuclei were
frozen at −80 °C until further processing. Around 60-80 E8.25 to
E9.0 embryos were pooled and lysed in nuclear lysis buffer
supplemented with protease and phosphatase inhibitors (50 mM
Tris pH 8.0, 1% SDS, 5 mM EDTA pH 8.0). Lysates were sonicated
with Bioruptor (Diagenode) to achieve fragment sizes in the range
of 200-500 bp. Lysates were diluted 1:10 in dilution buffer (50 mM
Tris pH8.0, 200mM NaCl, 5 mM EDTA pH8.0, 0.5% NP40) with
protease and phosphatase inhibitors and precleared with Protein
G Sepharose (GE Healthcare). Precleared lysates were incubated
with 2-5 µg anti-Isl1 antibody (DSHB, clone 39.4D5) overnight at
4 °C followed by pulldown with BSA-presaturated protein G
Sepharose beads. Immune complexes were washed with NaCl
wash buffer (20 mM Tris pH 8.0, 500mM NaCl, 2 mM EDTA pH 8.0,
0.1% SDS, 1% NP-40), LiCl wash buffer (20 mM Tris pH 8.0, 500 mM
LiCl, 2 mM EDTA pH 8.0, 0.1% SDS, 1% NP40) and TE wash buffer
(20 mM Tris pH 8.0, 2 mM EDTA pH 8.0). Protein/DNA complexes
were extracted in elution buffer (20 mM Tris pH 8.0, 2 mM EDTA
pH 8.0 and 2% SDS) followed by reverse crosslinking at 65 °C
overnight. DNA purification was performed using phenol-
chloroform and used for ChIP-qPCR analysis or ChIP- Seq.
ChIP-qPCR
For ChIP-qPCR analysis pools of 20 cardiogenic regions of E8.25-E9
embryos or 106 CPCs obtained by directed differentiation of ES
cells into cardiomyocytes were used. The following antibodies
were utilized: anti-Isl1 (39.4D5, DSHB), anti-Brg1 (Millipore, 07-478),
anti-Gata4 (Santa Cruz, sc-1237) and anti-H3 (Abcam, ab1791)
antibodies. Average threshold cycle (Ct) values were used to
calculate % enrichment compared to 1% input and negative
control region Ct value was used to calculate fold enrichment.
ChIP-Seq data analysis
ChIP-Seq reads were mapped to the mouse reference genome
mm9 (UCSC assembly) using the default settings of bowtie2. The
MarkDuplicates.jar from Picard 1.136 was used to remove PCR
artefacts. Peaks were called using MACS1460 with the parameter
(p1e8 –nomodel –shiftsize 80) for Isl1-ChIP-Seq and Gata4-ChIP-
exo (GSE72223) and (p1e3 –nomodel –shiftsize 80) for Brg1-ChIP-
Seq (GSE116281). Peaks overlapping blacklist defined by ENCODE
were removed. Bedtools v2.15 (intersect -wa)61 was used to find
the common binding areas in experimental replicates and
between the different Isl1-ChIP-Seq, Brg1-ChIP-Seq (GSE116281),
Gata4-ChIP-exo (GSE72223) and ATAC-Seq datasets. Genome wide
distribution of the reads was performed using ngs.plot with mm9
Ensembl (version 67) as reference annotation. ChIP-Seq peak
annotation was performed using annotatePeaks.pl (default
settings), which assigns each peak to the closest gene transcrip-
tional start site (TSS). For data visualization bam files were
converted to BigWig files using BamCoverage from deepTools262
(-b 20 -smooth 40 -e 150 –normalizeTo1x 2150570000). Venn
diagrams were generated with BioVenn online tools63 and protein
coding genes were used for all comparisons. Taq heatmaps were
created using ngsplot64 followed by a home made script.
ATAC-Sequencing
Pharyngeal mesoderm and hearts were dissected from E8.75
embryos (6 somites stage). Tissues and 100.000 CPCs from two
independent differentiations were resuspended in 50 uL cold lysis
buffer (10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1%
Igepal CA-630) and used for ATAC Library preparation using Tn5
Transposase from Nextera DNA Library Prep Kit (Illumina
#15028211). After centrifugation (10 min, 500 g at 4 °C), cell pellet
was resuspended in transposition reaction mix (25 µl TD-Buffer,
2.5 µl Tn5, 22.5 µl water) and incubated for 30min at 37 °C with
gentle mixing. Immediately following the transposition reaction,
purification was carried out using MinElute PCR Purification Kit
(Qiagen #28004). Amplification of Library together with indexing
was performed as described in.39 Libraries were mixed in
equimolar ratios and sequenced on NextSeq500 platform using
V2 chemistry. ATAC-Seq reads were mapped with bowtie2 to mm9
mouse genome. Samtools view (-F 1804 -f2) was used to remove
unmapped, mate unmapped, not primary aligned reads. The
MarkDuplicates.jar from Picard 1.136 was use to remove PCR
artefacts. Peaks calling was performed with MACS1460 (p1e5 –
nomodel and –shiftsize 100), and peaks overlapping blacklist
defined by ENCODE with the help of Bedtools v2.15
(intersect -wa).61 Similar to ChIP-Seq analysis, Bedtools v2.15
(intersect -wa) was used to obtain open chromatin regions
overlapping by at least 1 bp in the replicates. BamCoverage
function of deepTools262 (-b 20 -smooth 40 -e 150) was used to
create normalized bigwig files (reads per genome coverage,
RPGC). Further, bigWigAverageOverBed (https://github.com/
ENCODE-DCC/kentUtils) was used to quantify mapped reads on
peaks areas. Heatmap and densitity plots were created using
computeMatrix followed by plotHeatmap or plotProfile from
deepTools2.62 To permit a comparative display of data within a
deeptools profile heatmap,62 size factors produced by edgeR
based on unified peak counts were used to scale samples to
account for differences in sequencing depth, library composition,
and ATAC-Seq efficiency.
ATAC-Seq reads from three wild-type, three Isl1−/− and three
Isl1-Cre−/−/Brg1fl/fl E8.75 (6 somites) embryos and ESC-derived
CPCs from two independent differentiations were used for further
analysis.
Additional bioinformatic analysis
Gene ontology analysis was performed using DAVID Bioinfor-
matics Resources 6.8. The Isl1 regulated gene network presented
in Fig. 3d was built by submitting a curated list of Isl1 primary
downstream targets to the GeneMANIA web based software. The
network was subdivided into transcription factors, signaling
molecules, muscle structural and contractile genes involved in
heart development and visualized using Cytoscape.
Intersection of RNA-Seq and ChIP-Seq data was done by gene
name. Intersection of ATAC-Seq and ChIP-Seq peaks was
performed with Bedtools v2.15 (intersect -wa) to identify open
chromatin regions overlapping at least 1 bp with Isl1, Brg1 or
GATA4 bound sequences.
Gene list in GO terms related to cardiac muscle cell differentia-
tion, endothelial cell differentiation and smooth muscle cell
development/ differentiation was obtained from (http://amigo.
geneontology.org/amigo/landing). DeepTools262 was used to plot
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ATAC-Seq reads covering TSS of genes within the above
mentioned gene lists.
Protein expression and purification
6XHis tagged Isl1 DNA binding homeodomain (HD) protein65 was
expressed in E. Coli Rosetta DE3 cells and purified using Ni-NTA
agarose (Qiagen, 30210) under native conditions. Purified Isl1
protein was further dialyzed in TE (10 mM Tris pH 8.0 and 1mM
EDTA pH 8.0) overnight using Spectra/Por 3 basic dialysis unit
(Cat#132720), aliquoted and stored at −80 °C.
Nuclear extracts from Nkx2.5 overexpressing HEK293T cells
were prepared as follows: cells were scraped in 400ml of buffer A
(10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT,
protease inhibitor cocktail, and 0.5 mM PMSF) and incubated on
ice for 15 min. After centrifugation, the cell pellet was resus-
pended in 150 ml of buffer B (20 mM HEPES pH7.9, 1.5 mM MgCl2,
420mM NaCl, 0.2 mM EDTA, 25% v/v Glycerol, protease inhibitor
cocktail, and 0.5 mM PMSF) and incubated on ice with vigorous
agitation for 40 min. Nuclear extracts were recovered by
centrifugation for 15 min at 13,000 rpm and protein concentration
was determined by BCA method (Thermo Fisher Scientific Cat#
23225). Nuclear extracts were aliquoted and stored at −80 °C.
Nucleosome assembly
162 bp Ttn promoter DNA was PCR amplified from mouse
genomic DNA and cloned into pJET vector (Thermo Fisher
Scientific Cat# K1231). The genomic DNA used corresponds to
the following sequence:
CGGTGTCTGCTATCACTCAGTTTCATCCCTTTCTTCCCAAATGGCCA
GTTTCATGTTGTGTATCTTGACAGTGACTCCCAACCAGAGACTCCTGT
TAAGGGAACTTGTCAGTCATAATAGACAATAAGTGAACTTCTTGTTCG
GGGTGCTCAATAATTTGCT
Using biotin labeled PCR primers Ttn DNA was amplified and
purified using PCR cleanup kit (Qiagen, 28004). Purified human
recombinant histone H2A/H2B dimers (NEB#M2508S) and H3/H4
tetramers (NEB, M2509S) were purchased from NEB. DNA was
assembled into nucleosomes as described in.1 Briefly, 2 µg of
biotin labeled Ttn DNA was mixed with equimolar ratios of H2A/
H2B dimer and H3/H4 tetramers at 1:1.4 DNA:Histone Octamer
molar ratio in buffer containing 10mM Tris-HCl pH 8.0, 5 M urea, 2
M NaCl, 1 mM EDTA and 0.1 mg/ml BSA. Nucleosome assembly
was carried out using the salt gradient dialysis method with a
buffer series containing 2 M, 1.5 M, 1 M, 0.8 M and 0.6 M, NaCl in
10mM Tris pH 8.0, 1 mM EDTA pH 8.0, 5 M Urea and 10mM β-
mercaptoethanol at 4 °C. Buffer exchange was performed every 4
h. Finally, the nucleosomes were dialyzed in 0.6 M NaCl or 0.1 M
NaCl, 10 mM Tris pH 8.0, 1 mM EDTA pH 8.0 and 1mM β-
mercaptoethanol buffer without urea for 4 h and O/N respectively
at 4 °C.
Binding reactions and Electrophoretic mobility shift assays
Biotin labeled free Ttn DNA, nucleosomal Ttn DNA and
increasing concentrations of Isl1 protein (0 to 1 µM) or nuclear
extract from Nkx2.5 overexpressing cells were incubated in
binding buffer containing 40 mM KCl, 15 mM HEPES pH8.0, 1 mM
EDTA pH8.0, 0.5 mM DTT, 2 mM MgCl2, 5% glycerol, 10 ng/µl
poly dI/dC and 0.1 mg/ml BSA for 30 min at RT. The free and
bound DNA was resolved on 4% PAGE gel in 0.5X Tris borate-
EDTA (TBE) and transferred onto a Biodyne® B Nylon Membrane
(Thermo Fisher Scientific Cat# 77016) in 0.5X TBE for 1 h at 350
mAmp. Detection of the biotin-labeled DNA was performed with
Chemiluminescent Nucleic Acid Detection Module (Thermo
Fisher Scientific Cat# 89880) according to manufacturer’s
instructions. For competition assays 0.5 µM Isl1 protein was
used in combination with 80-fold molar excess of specific
(Insulin enhancer; 5′CCCTTGTTAAGACTCTAATTACCCTAG3′) and
nonspecific (NS; 5′CAAGCAAAACAAACCA3′) double stranded
oligos as competitors. Representative results of three
independent nucleosomal assembly, binding and competition
assays are presented.
Statistics and reproducibility
All experiments were performed at least three independent times
(unless noted otherwise) and respective data were used for
statistical analyses. Differences between groups were assessed
using a two-tailed Student’s t-test in Microsoft Excel. p values
represent significance p ≤ 0.05*, p ≤ 0.01**, p ≤ 0.005***.
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